For: | Filgueira NA. Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation. World J Hepatol 2019; 11(3): 261-272 [PMID: 30967904 DOI: 10.4254/wjh.v11.i3.261] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v11/i3/261.htm |
Number | Citing Articles |
1 |
Kartik S. Jhaveri, Ali Babaei Jandaghi, Rajesh Bhayana, Khaled Y. Elbanna, Osvaldo Espin-Garcia, Sandra E. Fischer, Anand Ghanekar, Gonzalo Sapisochin. Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00532-3
|
2 |
Parissa Tabrizian, Allen Yu, Neha Debnath, Bryan Myers, Thomas Marron. Immunotherapy and Liver Transplantation. Surgical Clinics of North America 2024; 104(1): 163 doi: 10.1016/j.suc.2023.07.009
|
3 |
Kuo‑Shyang Jeng, Chi‑Juei Jeng, Wen‑Juei Jeng, I‑Shyan Sheen, Shih‑Yun Li, Chuen‑Miin Leu, Yeou‑Guang Tsay, Chiung‑Fang Chang. Sonic Hedgehog signaling pathway as a potential target to inhibit the progression of hepatocellular carcinoma (Review). Oncology Letters 2019; doi: 10.3892/ol.2019.10826
|
4 |
Christof T. Kaltenmeier, Hamza Yazdani, Dirk van der Windt, Michele Molinari, David Geller, Allan Tsung, Samer Tohme. Neutrophil extracellular traps as a novel biomarker to predict recurrence-free and overall survival in patients with primary hepatic malignancies. HPB 2021; 23(2): 309 doi: 10.1016/j.hpb.2020.06.012
|
5 |
Monique J. C. Devillers, Johanna K. F. Pluimers, Maria C. van Hooff, Michail Doukas, Wojciech G. Polak, Robert A. de Man, Milan J. Sonneveld, Andre Boonstra, Caroline M. den Hoed. The Role of PIVKA-II as a Predictor of Early Hepatocellular Carcinoma Recurrence-Free Survival after Liver Transplantation in a Low Alpha-Fetoprotein Population. Cancers 2023; 16(1): 4 doi: 10.3390/cancers16010004
|
6 |
Stephen D. H. Malnick, Ali Abdullah, Manuela G. Neuman. Checkpoint Inhibitors and Hepatotoxicity. Biomedicines 2021; 9(2): 101 doi: 10.3390/biomedicines9020101
|
7 |
Fredrik Åberg, Jenny Abrahamsson, Andreas Schult, William Bennet, Magnus Rizell, Malin Sternby‐Eilard. The RETREAT score provides valid predictions regarding hepatocellular carcinoma recurrence after liver transplantation. Transplant International 2021; 34(12): 2869 doi: 10.1111/tri.14159
|
8 |
Rokas Stulpinas, Ieva Jakiunaite, Agne Sidabraite, Allan Rasmusson, Dovile Zilenaite-Petrulaitiene, Kestutis Strupas, Arvydas Laurinavicius, Aiste Gulla. Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria. Current Oncology 2024; 31(9): 5344 doi: 10.3390/curroncol31090394
|
9 |
Zahra Hajilou, Roya Solhi, Bahare Shokouhian, Shukoofeh Torabi, Zahra Heydari, Zahra Farzaneh, Sadaf Bahadori, Abbas Piryaei, Moustapha Hassan, Andreas K. Nussler, Massoud Vosough. Glioma-associated oncogene (GLI)-specific decoy oligodeoxynucleotide induces apoptosis and attenuates proliferation, colony formation, and migration in liver cancer cells. Hepatoma Research 2024; doi: 10.20517/2394-5079.2024.56
|
10 |
Christine Koch, Theresa Bette, Oliver Waidmann, Natalie Filmann, Christopher Schrecker, Jörg Trojan, Nina Weiler, Johannes Vermehren, Andreas A. Schnitzbauer, Wolf Otto Bechstein, Stefan Zeuzem, Eva Herrmann, Martin-Walter Welker, Gianfranco D. Alpini. AFP ratio predicts HCC recurrence after liver transplantation. PLOS ONE 2020; 15(7): e0235576 doi: 10.1371/journal.pone.0235576
|
11 |
Claudia Maccali, Aline L. Chagas, Ilka Boin, Emilio Quiñonez, Sebastián Marciano, Mario Vilatobá, Adriana Varón, Margarita Anders, Sergio Hoyos Duque, Agnaldo S. Lima, Josemaría Menendez, Martín Padilla‐Machaca, Jaime Poniachik, Rodrigo Zapata, Martín Maraschio, Ricardo Chong Menéndez, Linda Muñoz, Diego Arufe, Rodrigo Figueroa, Alejandro Soza, Martín Fauda, Simone R. Perales, Rodrigo Vergara Sandoval, Carla Bermudez, Oscar Beltran, Isabel Arenas Hoyos, Lucas McCormack, Francisco Juan Mattera, Adrián Gadano, Jose H. Parente García, Claudia Megumi Tani, Luiz Augusto Carneiro D’Albuquerque, Flair J. Carrilho, Marcelo Silva, Federico Piñero. Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort. Liver International 2021; 41(4): 851 doi: 10.1111/liv.14736
|
12 |
Sven H. Loosen, Hans H. Bock, Martin Hellmich, Wolfram T. Knoefel, Christian Trautwein, Verena Keitel, Johannes G. Bode, Ulf P. Neumann, Tom Luedde. Hospital Mortality and Current Trends in Liver Transplantation in Germany. Deutsches Ärzteblatt international 2021; doi: 10.3238/arztebl.m2021.0210
|
13 |
Pinzhe Zhang, Guanghao Zhu, Leping Li, Guanzhi Lai, Zekang Wang, Chengjun Sun, Wuzheng Xia, Linwei Wu. Immune checkpoint inhibitor therapy for malignant tumors in liver transplantation recipients: A systematic review of the literature. Transplantation Reviews 2022; 36(4): 100712 doi: 10.1016/j.trre.2022.100712
|
14 |
Aswathy R. Devan, Bhagyalakshmi Nair, Manu Kanjoormana Aryan, Vijayastelar B. Liju, Joel Joy Koshy, Bijo Mathew, Arun Valsan, Hoon Kim, Lekshmi R. Nath. Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence. Cancers 2023; 15(10): 2729 doi: 10.3390/cancers15102729
|
15 |
Baris Sarici, Burak Isik, Sezai Yilmaz. Management of Recurrent HCC After Liver Transplantation. Journal of Gastrointestinal Cancer 2020; 51(4): 1197 doi: 10.1007/s12029-020-00498-6
|
16 |
Ahmed Nasser, Victoria Smith, Niamh Campbell, Michael Devin Rivers-Bowerman, Ashley Elispath Stueck, Andreu Francesc Costa, Riley Arseneau, Lauren Westhaver, Boris Luis Gala-Lopez. Is hepatocellular carcinoma viability important when using intraoperative blood salvage during liver transplantation?. International Journal of Gastrointestinal Intervention 2023; 12(3): 145 doi: 10.18528/ijgii230020
|
17 |
Bhrugun Anisetti, Ahmed K. Ahmed, Tucker Coston, Lindsay Gardner, Umair Majeed, Jordan Reynolds, Hani Babiker. Delayed brain metastasis in recurrent hepatocellular carcinoma following liver transplantation: a case report highlighting the predictive value of microvascular invasion. Clinical Journal of Gastroenterology 2023; 16(6): 864 doi: 10.1007/s12328-023-01839-1
|
18 |
Burak Isik, Fatih Gonultas, Tolga Sahin, Sezai Yilmaz. Microvascular Venous Invasion in Hepatocellular Carcinoma: Why Do Recurrences Occur?. Journal of Gastrointestinal Cancer 2020; 51(4): 1133 doi: 10.1007/s12029-020-00487-9
|
19 |
Kawaljit Kaur, Anahid Jewett.
Supercharged NK Cell-Based Immuotherapy in Humanized Bone Marrow Liver and Thymus (Hu-BLT) Mice Model of Oral, Pancreatic, Glioblastoma, Hepatic, Melanoma and Ovarian Cancers
. Critical Reviews in Immunology 2023; 43(2): 13 doi: 10.1615/CritRevImmunol.2023050618
|
20 |
He Xu, Wenjie Wei, Mu Y., Chengwei Dong. Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis. Bioscience Reports 2020; 40(1) doi: 10.1042/BSR20194019
|
21 |
Shruthi H.S. Reddy, Neil Mehta, Jennifer L. Dodge, Abdul R. Hakeem, Shirin E. Khorsandi, Wayel Jassem, Hector Vilca-Melendez, Miriam Cortes-Cerisuelo, Parthi Srinivasan, Andreas Prachalias, Michael A. Heneghan, Varuna Aluvihare, Abid Suddle, Rosa Miquel, Mohamed Rela, Nigel D. Heaton, Krishna V. Menon. Liver transplantation for HCC: validation of prognostic power of the RETREAT score for recurrence in a UK cohort. HPB 2022; 24(5): 596 doi: 10.1016/j.hpb.2021.09.008
|
22 |
Tae Yun Lee, Ho Joong Choi, Joseph Ahn, Tae Ho Hong, Young-Kyoung You. Efficacy of Tumor Markers After Liver Transplantation In Patients With Hepatocellular Carcinoma. Transplantation Proceedings 2022; 54(2): 461 doi: 10.1016/j.transproceed.2022.01.007
|
23 |
Atit Dharia, Jacinthe Boulet, Vikas S. Sridhar, Abhijat Kitchlu. Cancer Screening in Solid Organ Transplant Recipients: A Focus on Screening Liver, Lung, and Kidney Recipients for Cancers Related to the Transplanted Organ. Transplantation 2022; 106(1): e64 doi: 10.1097/TP.0000000000003773
|
24 |
Bolun Zhang, Junshuai Xue, Bowen Xu, Jianping Chang, Xin Li, Zhen Huang, Hong Zhao, Jianqiang Cai. DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-61615-0
|
25 |
Jason T. Cheng, Michael L. Volk. Positron Emission Tomography Scan in Detecting and Locating Extrahepatic Recurrent Hepatocellular Carcinoma Post Orthotic Liver Transplant. Progress in Transplantation 2020; 30(4): 396 doi: 10.1177/1526924820958135
|
26 |
Jacob Zaemes, Muneeb Rehman, Coleman Smith, Ruth He. Immune Checkpoint Inhibitors - New Insights and Recent Progress. 2023; doi: 10.5772/intechopen.107097
|
27 |
Simone Famularo, Camilla Penzo, Cesare Maino, Flavio Milana, Riccardo Oliva, Jacques Marescaux, Michele Diana, Fabrizio Romano, Felice Giuliante, Francesco Ardito, Gian Luca Grazi, Matteo Donadon, Guido Torzilli. Preoperative detection of hepatocellular carcinoma's microvascular invasion on CT-scan by machine learning and radiomics: A preliminary analysis. European Journal of Surgical Oncology 2024; : 108274 doi: 10.1016/j.ejso.2024.108274
|
28 |
Jenny Abrahamsson, Malin Sternby Eilard, Magnus Rizell, William Bennett, Fredrik Åberg. Reduced calcineurin inhibitor exposure with antibody induction and recurrent hepatocellular carcinoma after liver transplantation. Scandinavian Journal of Gastroenterology 2022; 57(3): 325 doi: 10.1080/00365521.2021.2010799
|
29 |
Jian-Hua Li, Tuo Chen, Hao Xing, Rui-Dong Li, Cong-Huan Shen, Quan-Bao Zhang, Yi-Feng Tao, Zheng-Xin Wang. The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2023; 22(3): 245 doi: 10.1016/j.hbpd.2022.04.003
|
30 |
Li-Hsiang Yen, John C. Sabatino. Imaging complications of liver transplantation: a multimodality pictorial review. Abdominal Radiology 2021; 46(6): 2444 doi: 10.1007/s00261-019-02270-2
|
31 |
Lisa Kojima, Miho Akabane, Matthew Murray, Michael Fruscione, Daiki Soma, Abigail Snyder, John McVey, Daniel J. Firl, Roberto Hernandez-Alejandro, Chandrashekhar A. Kubal, James F. Markmann, Federico N. Aucejo, Koji Tomiyama, Shoko Kimura, Kazunari Sasaki. Reappraisal of tacrolimus levels after liver transplant for HCC: A multicenter study toward personalized immunosuppression regimen. Liver Transplantation 2024; doi: 10.1097/LVT.0000000000000459
|
32 |
Xuanfeng Zhang, Dong Zhang, Xuefeng Bu, Xinhui Zhang, Long Cui. Identification of a novel miRNA-based recurrence and prognosis prediction biomarker for hepatocellular carcinoma. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-05040-y
|
33 |
Ziqin He, Xiaomin She, Ziyu Liu, Xing Gao, Lu Lu, Julu Huang, Cheng Lu, Yan Lin, Rong Liang, Jiazhou Ye. Advances in post-operative prognostic models for hepatocellular carcinoma. Journal of Zhejiang University-SCIENCE B 2023; 24(3): 191 doi: 10.1631/jzus.B2200067
|
34 |
Matthew G Garas, Luis Calzadilla-Bertot, Briohny W Smith, Luc Delriviere, Byron Jaques, Lingjun Mou, Leon A Adams, Gerry C MacQuillan, George Garas, Gary P Jeffrey, Michael C Wallace. Hepatocellular carcinoma recurrence after liver transplant: An Australian single-centre study. World Journal of Transplantation 2025; 15(1): 99004 doi: 10.5500/wjt.v15.i1.99004
|
35 |
Emrah Sahin, Volkan Ince, Tolga T. Sahin, Ramazan Kutlu, Ramazan Pasahan, Sezai Yilmaz. Undetectable Brain Metastasis of Hepatocellular Carcinoma by PET-CT After Liver Transplantation: a Case Report. Journal of Gastrointestinal Cancer 2023; 54(1): 270 doi: 10.1007/s12029-021-00767-y
|
36 |
Dong-Sik Kim, Young-In Yoon, Beom Kyung Kim, Ashok Choudhury, Anand Kulkarni, Jun Yong Park, Jongman Kim, Dong Hyun Sinn, Dong Jin Joo, YoungRok Choi, Jeong-Hoon Lee, Ho Joong Choi, Ki Tae Yoon, Sun Young Yim, Cheon-Soo Park, Deok-Gie Kim, Hae Won Lee, Won-Mook Choi, Young Eun Chon, Woo-Hyoung Kang, Jinsoo Rhu, Jae Geun Lee, Yuri Cho, Pil Soo Sung, Han Ah Lee, Ji Hoon Kim, Si Hyun Bae, Jin Mo Yang, Kyung-Suk Suh, Mamun Al Mahtab, Soek Siam Tan, Zaigham Abbas, Ananta Shresta, Shahinul Alam, Anil Arora, Ashish Kumar, Pravin Rathi, Ruveena Bhavani, Charles Panackel, Kuei Chuan Lee, Jun Li, Ming-Lung Yu, Jacob George, Tawesak Tanwandee, Sen-Yung Hsieh, Chee Chien Yong, Mohamed Rela, H. C. Lin, Masao Omata, Shiv Kumar Sarin. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation. Hepatology International 2024; 18(2): 299 doi: 10.1007/s12072-023-10629-3
|
37 |
Joana Espírito Santo, Ana Ladeirinha, Ana Alarcão, Eugeniu Strelet, Marco Reis, Rui Santos, Lina Carvalho. Hepatocellular carcinoma: tumor heterogeneity and recurrence after preoperative locoregional therapy. Medical Oncology 2023; 40(12) doi: 10.1007/s12032-023-02208-1
|
38 |
Filippos F. Karageorgos, Konstantina-Eleni Karakasi, Stella Vasileiadou, Athanasios Kofinas, Nikolaos Antoniadis, Georgios Katsanos, Georgios Tsoulfas. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_261
|
39 |
Maria C. van Hooff, Milan J. Sonneveld, Jan N. Ijzermans, Michail Doukas, Dave Sprengers, Herold J. Metselaar, Caroline M. den Hoed, Robert A. de Man. External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers 2022; 14(3): 630 doi: 10.3390/cancers14030630
|
40 |
Maciej Gryziak, Rafał Stec, Krzysztof Woźniak, Benedykt Szczepankiewicz, Maciej Krasnodębski, Michał Grąt, Leszek Kraj. Prognostic factors for hepatocellular carcinoma recurrence after liver transplantation or resection – single-center experience. Heliyon 2024; 10(22): e40228 doi: 10.1016/j.heliyon.2024.e40228
|
41 |
Tommaso Innocenti, Andrea Galli, Stefano Milani, Gabriele Dragoni, Claudia Campani, Erica Nicola Lynch, Lorenzo Anastasio, Elisa Fuochi. Main factors influencing long-term outcomes of liver transplantation in 2022. World Journal of Hepatology 2023; 15(3): 321-352 doi: 10.4254/wjh.v15.i3.321
|
42 |
Antonio Cuadrado, José Ignacio Fortea, Carlos Rodríguez-Lope, Ángela Puente, Vanesa Fernández-Vilchez, Victor Jose Echavarria, Federico José Castillo Suescun, Roberto Fernández, Juan Andrés Echeverri, Mar Achalandabaso, Enrique Toledo, Raúl Pellón, Juan Carlos Rodríguez Sanjuan, Javier Crespo, Emilio Fábrega. Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant Patients. Journal of Clinical Medicine 2023; 12(17): 5457 doi: 10.3390/jcm12175457
|
43 |
Li Pang, Lei-bo Xu, Wen-rui Wu. Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options. Transplantation Proceedings 2024; 56(6): 1396 doi: 10.1016/j.transproceed.2024.05.041
|
44 |
Mayara Regina Galdino-Vasconcelos, Mateus Silva Feijó, Henrique Metzker Ferro, Ana Clara Ramalho Gomes, Maria Eduarda De Almeida Santos, Gustavo Ferreira, Fernando Jorge, Natália Trevizoli, Luiz Gustavo Diaz, Priscila Brizolla De Campos, Gabriel Cajá, Raquel Ullmann, Ana Virgínia Figueira, Tiago Morato, André Luís Conde Watanabe. Preoperative Alpha-Fetoprotein and Radiological Total Tumor Diameter as Predictors of Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplantation Proceedings 2022; 54(5): 1333 doi: 10.1016/j.transproceed.2022.02.065
|
45 |
Christopher Buros, Atman Ashwin Dave, Alessandro Furlan. Immediate and Late Complications After Liver Transplantation. Radiologic Clinics of North America 2023; 61(5): 785 doi: 10.1016/j.rcl.2023.04.002
|
46 |
Elizabeth V. Craig, Matthew T. Heller. Complications of liver transplant. Abdominal Radiology 2021; 46(1): 43 doi: 10.1007/s00261-019-02340-5
|
47 |
Stephanie M. Woo, Alexandra V. Kimchy, Lynette M. Sequeira, Charles S. Dorris, Aiwu R. He, Amol S. Rangnekar. Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma. Current Oncology 2022; 29(12): 9813 doi: 10.3390/curroncol29120771
|
48 |
Kinga Czarnecka, Paulina Czarnecka, Olga Tronina, Teresa Bączkowska, Magdalena Durlik. Body Mass Index: An Unreliable Adiposity Indicator for Predicting Outcomes of Liver Transplantation Due to Hepatocellular Carcinoma. Gastrointestinal Disorders 2024; 6(3): 607 doi: 10.3390/gidisord6030040
|
49 |
Tommaso Giuliani, Eva Montalvá, Javier Maupoey, Andrea Boscá, Ana Hernando, David Calatayud, Vicente Navarro, Angel Rubín, Carmen Vinaixa, Rafael López-Andújar. Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments. Digestive Surgery 2024; 41(4): 181 doi: 10.1159/000539460
|
50 |
Haytham Derbel, Athena Galletto Pregliasco, Sébastien Mulé, Julien Calderaro, Youssef Zaarour, Laetitia Saccenti, Mario Ghosn, Edouard Reizine, Maxime Blain, Alexis Laurent, Raffaele Brustia, Vincent Leroy, Giuliana Amaddeo, Alain Luciani, Vania Tacher, Hicham Kobeiter. Should Hypervascular Incidentalomas Detected on Per-Interventional Cone Beam Computed Tomography during Intra-Arterial Therapies for Hepatocellular Carcinoma Impact the Treatment Plan in Patients Waiting for Liver Transplantation?. Cancers 2024; 16(13): 2333 doi: 10.3390/cancers16132333
|
51 |
Bo Hu, Xiao-Bo Yang, Xin-Ting Sang. Liver graft rejection following immune checkpoint inhibitors treatment: a review. Medical Oncology 2019; 36(11) doi: 10.1007/s12032-019-1316-7
|
52 |
Shagun Rangra, Dhwani Rana, Arvee Prajapati, Derajram Benival, Pradeep Dwivedi, Amit Mandoli. Nutritional and microbiota-based therapeutic interventions for alcohol-associated liver disease: From pathogenesis to therapeutic insights. Life Sciences 2024; 352: 122852 doi: 10.1016/j.lfs.2024.122852
|
53 |
Po-Jung Hsu, Hao-Chien Hung, Jin-Chiao Lee, Yu-Chao Wang, Chih-Hsien Cheng, Tsung-Han Wu, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee, Chen-Fang Lee. Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant Patients. Current Oncology 2021; 28(6): 4281 doi: 10.3390/curroncol28060364
|
54 |
Sungmin Kang, Joo Dong Kim, Dong Lak Choi, Byungwook Choi. Predicting the Recurrence of Hepatocellular Carcinoma after Primary Living Donor Liver Transplantation Using Metabolic Parameters Obtained from 18F-FDG PET/CT. Journal of Clinical Medicine 2022; 11(2): 354 doi: 10.3390/jcm11020354
|
55 |
Nicolò Brandi, Matteo Renzulli. The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(10): 8598 doi: 10.3390/ijms24108598
|
56 |
Riccardo Pravisani, Maria De Martino, Federico Mocchegiani, Fabio Melandro, Damiano Patrono, Andrea Lauterio, Fabrizio Di Francesco, Matteo Ravaioli, Marco Fabrizio Zambelli, Claudio Bosio, Daniele Dondossola, Quirino Lai, Matteo Zanchetta, Jule Dingfelder, Luca Toti, Alessandro Iacomino, Sermed Nicolae, Davide Ghinolfi, Renato Romagnoli, Luciano De Carlis, Salvatore Gruttadauria, Matteo Cescon, Michele Colledan, Amedeo Carraro, Lucio Caccamo, Marco Vivarelli, Massimo Rossi, Silvio Nadalin, Georg Gyori, Giuseppe Tisone, Giovanni Vennarecci, Andreas Rostved, Paolo De Simone, Miriam Isola, Umberto Baccarani. Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma. Liver Transplantation 2024; 30(10): 1002 doi: 10.1097/LVT.0000000000000373
|
57 |
Morteza Hafezi, Meiyin Lin, Adeline Chia, Alicia Chua, Zi Zong Ho, Royce Fam, Damien Tan, Joey Aw, Andrea Pavesi, Thinesh Lee Krishnamoorthy, Wan Cheng Chow, Wenjie Chen, Qi Zhang, Lu‐En Wai, Sarene Koh, Anthony T. Tan, Antonio Bertoletti. Immunosuppressive Drug‐Resistant Armored T‐Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients. Hepatology 2021; 74(1): 200 doi: 10.1002/hep.31662
|
58 |
Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin P. Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review. International Journal of Molecular Sciences 2023; 24(3): 2358 doi: 10.3390/ijms24032358
|
59 |
Benoit Schmauch, Sarah S. Elsoukkary, Amika Moro, Roma Raj, Chase J. Wehrle, Kazunari Sasaki, Julien Calderaro, Patrick Sin-Chan, Federico Aucejo, Daniel E. Roberts. Combining a deep learning model with clinical data better predicts hepatocellular carcinoma behavior following surgery. Journal of Pathology Informatics 2023; : 100360 doi: 10.1016/j.jpi.2023.100360
|
60 |
Niccolò Incarbone, Riccardo De Carlis, Leonardo Centonze, Davide Paolo Bernasconi, Maria Grazia Valsecchi, Andrea Lauterio, Luciano De Carlis. The impact of postoperative complications on oncological outcomes of liver transplantation for hepatocellular carcinoma: A competing risk analysis. Digestive and Liver Disease 2023; 55(12): 1690 doi: 10.1016/j.dld.2023.05.026
|
61 |
Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium. Liver Transplantation 2023; 29(1): 34 doi: 10.1097/LVT.0000000000000007
|
62 |
Kylie E Zane, Paul B Nagib, Sajid Jalil, Khalid Mumtaz, Mina S Makary. Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma. World Journal of Hepatology 2022; 14(5): 885-895 doi: 10.4254/wjh.v14.i5.885
|
63 |
Wenjie Miao, Pei Nie, Guangjie Yang, Yangyang Wang, Lei Yan, Yujun Zhao, Ting Yu, Mingming Yu, Fengyu Wu, Wei Rao, Zhenguang Wang. An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation. European Journal of Nuclear Medicine and Molecular Imaging 2021; 48(11): 3656 doi: 10.1007/s00259-021-05328-w
|
64 |
Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Jianhua Wang, Mengsu Zeng, Weiping Zhou, Ping Bie, Lianxin Liu, Tianfu Wen, Guohong Han, Maoqiang Wang, Ruibao Liu, Ligong Lu, Zhengang Ren, Minshan Chen, Zhaochong Zeng, Ping Liang, Changhong Liang, Min Chen, Fuhua Yan, Wenping Wang, Yuan Ji, Jingping Yun, Dingfang Cai, Yongjun Chen, Wenwu Cheng, Shuqun Cheng, Chaoliu Dai, Wenzhi Guo, Baojin Hua, Xiaowu Huang, Weidong Jia, Yaming Li, Yexiong Li, Jun Liang, Tianshu Liu, Guoyue Lv, Yilei Mao, Tao Peng, Weixin Ren, Hongcheng Shi, Guoming Shi, Kaishan Tao, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bangde Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang, Shenglong Ye, Zhengyu Yin, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yongfu Zhao, Honggang Zheng, Jiye Zhu, Kangshun Zhu, Rong Liu, Yinghong Shi, Yongsheng Xiao, Zhi Dai, Gaojun Teng, Jianqiang Cai, Weilin Wang, Xiujun Cai, Qiang Li, Feng Shen, Shukui Qin, Jiahong Dong, Jia Fan. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer 2020; 9(6): 682 doi: 10.1159/000509424
|
65 |
Justin K. H. Liu, Andrew F. Irvine, Rebecca L. Jones, Adel Samson. Immunotherapies for hepatocellular carcinoma. Cancer Medicine 2022; 11(3): 571 doi: 10.1002/cam4.4468
|
66 |
Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maja Segedi, David M. Liu. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews 2023; 115: 102526 doi: 10.1016/j.ctrv.2023.102526
|
67 |
Olanrewaju Eletta, Shimul A. Shah. Does hepatectomy technique matter?. Liver Transplantation 2024; 30(10): 977 doi: 10.1097/LVT.0000000000000404
|
68 |
Patrick Gidley, Anand Patel, Guliz A. Barkan, Anugayathri Jawahar. An Atypical Presentation of Hepatocellular Carcinoma with Multisite Metastasis following a Curative Liver Transplant. Indian Journal of Radiology and Imaging 2023; 33(03): 420 doi: 10.1055/s-0043-1767694
|
69 |
Cheng-Maw Ho, Rey-Heng Hu, Yao-Ming Wu, Ming-Chih Ho, Po-Huang Lee. Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation. Clinical Medicine Insights: Oncology 2020; 14 doi: 10.1177/1179554920968774
|
70 |
Helio Tedesco-Silva, Faouzi Saliba, Markus J. Barten, Paolo De Simone, Luciano Potena, Jens Gottlieb, Apurva Gawai, Peter Bernhardt, Julio Pascual. An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients. Transplantation Reviews 2022; 36(1): 100655 doi: 10.1016/j.trre.2021.100655
|
71 |
Khalid Ibrahim Bzeizi, Ahmed Adan, Dieter Clemens Broering. Transplant Oncology. 2025; : 205 doi: 10.1016/B978-0-443-21901-6.00017-3
|
72 |
Haris Muhammad, Aniqa Tehreem, Peng-Sheng Ting, Merve Gurakar, Sean Young Li, Cem Simsek, Saleh A. Alqahtani, Amy K. Kim, Ruhail Kohli, Ahmet Gurakar. Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00125
|
73 |
Kin-Pan Au, Wing-Chiu Dai, Albert Chi-Yan Chan, Tan-To Cheung, Chung-Mau Lo, Kenneth Siu-Ho Chok. Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence. Transplantation Direct 2021; 7(10): e769 doi: 10.1097/TXD.0000000000001213
|
74 |
Riccardo Nevola, Rachele Ruocco, Livio Criscuolo, Angela Villani, Maria Alfano, Domenico Beccia, Simona Imbriani, Ernesto Claar, Domenico Cozzolino, Ferdinando Carlo Sasso, Aldo Marrone, Luigi Elio Adinolfi, Luca Rinaldi. Predictors of early and late hepatocellular carcinoma recurrence. World Journal of Gastroenterology 2023; 29(8): 1243-1260 doi: 10.3748/wjg.v29.i8.1243
|
75 |
Michelle R. Ju, Adam C. Yopp. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience. Annals of Gastroenterological Surgery 2020; 4(3): 208 doi: 10.1002/ags3.12316
|
76 |
Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Mengsu Zeng, Weiping Zhou, Ping Bie, Lianxin Liu, Tianfu Wen, Ming Kuang, Guohong Han, ZhiPing Yan, Maoqiang Wang, Ruibao Liu, Ligong Lu, Zhenggang Ren, ZhaoChong Zeng, Ping Liang, Changhong Liang, Min Chen, Fuhua Yan, Wenping Wang, Jinlin Hou, Yuan Ji, Jingping Yun, Xueli Bai, Dingfang Cai, Weixia Chen, Yongjun Chen, Wenwu Cheng, Shuqun Cheng, Chaoliu Dai, Wenzhi Guo, Yabing Guo, Baojin Hua, Xiaowu Huang, Weidong Jia, Qiu Li, Tao Li, Xun Li, Yaming Li, Yexiong Li, Jun Liang, Changquan Ling, Tianshu Liu, Xiufeng Liu, Shichun Lu, Guoyue Lv, Yilei Mao, Zhiqiang Meng, Tao Peng, Weixin Ren, Hongcheng Shi, Guoming Shi, Ming Shi, Tianqiang Song, Kaishan Tao, Jianhua Wang, Kui Wang, Lu Wang, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bangde Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang, Shenglong Ye, Zhenyu Yin, Yong Zeng, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yanqiao Zhang, Ming Zhao, Yongfu Zhao, Honggang Zheng, Ledu Zhou, Jiye Zhu, Kangshun Zhu, Rong Liu, Yinghong Shi, Yongsheng Xiao, Lan Zhang, Chun Yang, Zhifeng Wu, Zhi Dai, Minshan Chen, Jianqiang Cai, Weilin Wang, Xiujun Cai, Qiang Li, Feng Shen, Shukui Qin, Gaojun Teng, Jiahong Dong, Jia Fan. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition). Liver Cancer 2023; 12(5): 405 doi: 10.1159/000530495
|
77 |
Ariel Jaffe, Tamar H. Taddei, Edoardo G. Giannini, Ysabel C. Ilagan‐Ying, Massimo Colombo, Mario Strazzabosco. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook. Liver International 2022; 42(12): 2607 doi: 10.1111/liv.15432
|
78 |
Khalid I. Bzeizi, Maheeba Abdullah, Kota Vidyasagar, Saleh A. Alqahthani, Dieter Broering. Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence. Cancers 2022; 14(20): 5114 doi: 10.3390/cancers14205114
|
79 |
Eleni Avramidou, Stella Vasileiadou, Georgios Tsoulfas. Liver Transplantation - Challenges and Opportunities. 2024; doi: 10.5772/intechopen.1004821
|
80 |
Darren J. H. Tan, Chloe Wong, Cheng Han Ng, Chen Wei Poh, Sneha Rajiv Jain, Daniel Q. Huang, Mark D. Muthiah. A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity. Journal of Clinical Medicine 2021; 10(2): 238 doi: 10.3390/jcm10020238
|
81 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and management. Liver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
|
82 |
Raphael Iglesias de Oliveira Vidal, Edison Iglesias de Oliveira Vidal, Basilio de Bragança Pereira, Cachimo Combo Assane, Alexandre Ribeiro, Emilia Matos do Nascimento, Fernando Gomes Romeiro, Joaquim Ribeiro Filho, Ran Wang. Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1487593
|
83 |
Islam B. Mohamed, Mohamed Saleh Ismail, Ahmed El Sabagh, Ahmed M. Afifi Abdelwahab, Efstathia Polychronopoulou, Yong‐Fang Kuo, Manal Hassan, John A. Goss, Fasiha Kanwal, Prasun K. Jalal. Radiological‐histopathological discordance in patients transplanted for HCC and its impact on post‐transplant outcomes. Cancer Medicine 2023; 12(14): 15011 doi: 10.1002/cam4.6161
|
84 |
Jayshri A. Shah. Peri-operative Anesthetic Management in Liver Transplantation. 2023; : 551 doi: 10.1007/978-981-19-6045-1_41
|
85 |
Kin-Pan Au, James Yan-Yue Fung, Wing-Chiu Dai, Albert Chi-Yan Chan, Chung-Mau Lo, Kenneth Siu-Ho Chok. Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation. Journal of Clinical Medicine 2022; 11(15): 4389 doi: 10.3390/jcm11154389
|